Literature DB >> 21172602

Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting.

Christine Y Lu1, John Barratt, Agnes Vitry, Elizabeth Roughead.   

Abstract

OBJECTIVE: To compare the performance of Charlson index and Rx-Risk score using data from Australian Department of Veterans' Affairs. STUDY DESIGN AND
SETTING: A study of older adults (N=94,714) who had both Charlson and Rx-Risk scores based on their hospital diagnoses and prescription medication dispensings during the baseline year (January 2005-December 2005). Predictive ability of 1-year and 3-year mortality was compared by Akaike information criterion model fit statistic and c statistic in logistic regression models. We also compared the scores for identifying specific medical conditions.
RESULTS: Both indices were significant predictors of all-cause mortality (P<0.0001). Of the population identified with a condition from either score, Rx-Risk score identified more than 95% of patients with gastric, respiratory, or cardiovascular condition, compared with Charlson index only identifying 2%, 31%, and 14%, respectively. The indices were comparable regarding diabetes. The Charlson index identified 83% of patients with dementia and 67% of those with cancers, whereas Rx-Risk score identified 38% and 43%, respectively.
CONCLUSION: Both the Charlson and Rx-Risk scores predict mortality, but neither index identified all comorbidities. Based on data availability, preferences, and research purposes, investigators can use either Charlson index or Rx-Risk score to adjust for comorbidity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21172602     DOI: 10.1016/j.jclinepi.2010.02.015

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  30 in total

1.  A population-based study of transdermal fentanyl initiation in Australian clinical practice.

Authors:  Natasa Gisev; Sallie-Anne Pearson; Briony Larance; Sarah Larney; Bianca Blanch; Louisa Degenhardt
Journal:  Eur J Clin Pharmacol       Date:  2018-11-03       Impact factor: 2.953

2.  The Impact of Medication-Based Risk Adjustment on the Association Between Veteran Health Outcomes and Dual Health System Use.

Authors:  Thomas R Radomski; Xinhua Zhao; Carolyn T Thorpe; Joshua M Thorpe; Jennifer G Naples; Maria K Mor; Chester B Good; Michael J Fine; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2017-05-01       Impact factor: 5.128

3.  Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated.

Authors:  Natasa Gisev; Sallie-Anne Pearson; Bianca Blanch; Briony Larance; Timothy Dobbins; Sarah Larney; Louisa Degenhardt
Journal:  Br J Clin Pharmacol       Date:  2016-07-18       Impact factor: 4.335

4.  Prevalence and Factors Associated with Analgesic Prescribing in Poly-Medicated Elderly Patients.

Authors:  Aymen Ali Al-Qurain; Lemlem G Gebremichael; Muhammad Suleman Khan; Desmond B Williams; Lorraine Mackenzie; Craig Phillips; Patrick Russell; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2020-04       Impact factor: 3.923

5.  Development and validation of a Medicines Comorbidity Index for older people.

Authors:  Sujita W Narayan; Prasad S Nishtala
Journal:  Eur J Clin Pharmacol       Date:  2017-09-11       Impact factor: 2.953

6.  Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare.

Authors:  Thomas R Radomski; Xinhua Zhao; Joseph T Hanlon; Joshua M Thorpe; Carolyn T Thorpe; Jennifer G Naples; Florentina E Sileanu; John P Cashy; Jennifer A Hale; Maria K Mor; Leslie R M Hausmann; Julie M Donohue; Katie J Suda; Kevin T Stroupe; Chester B Good; Michael J Fine; Walid F Gellad
Journal:  Healthc (Amst)       Date:  2019-04-26

7.  New users of antidepressant medications: first episode duration and predictors of discontinuation.

Authors:  Christine Y Lu; Elizabeth Roughead
Journal:  Eur J Clin Pharmacol       Date:  2011-06-29       Impact factor: 2.953

8.  Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia.

Authors:  Aymen Ali Al-Qurain; Lemlem G Gebremichael; Mohammed S Khan; Desmond B Williams; Lorraine Mackenzie; Craig Phillips; Patrick Russell; Michael S Roberts; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2020-11-18

9.  Predictors of persistent prescription opioid analgesic use among people without cancer in Australia.

Authors:  Samanta Lalic; Natasa Gisev; J Simon Bell; Maarit Jaana Korhonen; Jenni Ilomäki
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

10.  Prevalence and incidence of prescription opioid analgesic use in Australia.

Authors:  Samanta Lalic; Jenni Ilomäki; J Simon Bell; Maarit Jaana Korhonen; Natasa Gisev
Journal:  Br J Clin Pharmacol       Date:  2018-11-16       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.